Get research updatesDepression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
This study evaluates the safety and effectiveness of MK-1942 for people with depression.
This study ended early.
Multiple locations, including BirminghamA Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including TusconA Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression
This study is no longer accepting new participants.
Multiple locations, including Gilbert
A Clinical Evaluation of Different Device Parameters for the Management of Patients With Treatment Resistant Major Depressive Disorder, Single or Recurrent Episode, With Deep Brain Stimulation
This study has finished and is no longer accepting participants.
Multiple locations, including NiceThis study evaluated the safety and effectiveness of ALA-3000 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Little Rock
This study has finished and is no longer accepting participants.
In Palma de MallorcaInduction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study
This study is no longer accepting new participants.
In Chapel HillThe Efficacy of Psychoeducational Family Intervention for Individuals With Major Depression: a Randomized Controlled Trial
Current recruitment status is unconfirmed.
In NaplesPrecision Targeting of Propofol-induced Electroencephalographic Slow Waves: a Novel Phase I Paradigm for Treatment-resistant Major Depressive Disorder
This study has finished and is no longer accepting participants.
In St LouisA Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Single Subcutaneous MIJ821 Injection in Addition to Standard of Care in Participants With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamA Feasibility Study of Transcranial Direct Current Stimulation (tDCS) as an Adjunctive Treatment for Treatment Resistant Depression (TRD) in Hospitalized Patients
This study is no longer accepting new participants.
In RochesterResearchers compared AGN-241751 and placebo to find out how the approaches affected depression symptoms in adults with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including FayettevilleWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.